Charity Search / D-FEET CANCER THE DALTON FOX FOUNDATION
Medical Research (H30) IRS Verified DX Registered 990 on File

D-FEET CANCER THE DALTON FOX FOUNDATION

EIN: 87-2231491 · VIRGINIA BCH, VA 23454-2601 · United States · FY 2024 Data
4 out of 5 66 / 100 Based on 2+ years of filings
Financial strength (30%) 84/100
Reliability (20%) 45/100
Effectiveness (25%) 68/100
Impact (25%) 60/100
Financial data: FY 2023 · Scored 9/13/2026
Claim this Charity
D-FEET CANCER THE DALTON FOX FOUNDATION logo
CharityAI™ Score
Not yet evaluated
Mission Statement

D-Feet Cancer The Dalton Fox Foundation raises awareness of Ewing Sarcoma and other under-studied pediatric cancers. By directly funding research into these cancers, we are determined to help discover more effective and less toxic treatments while supporting both patients and families during their greatest time of need.

Financial Overview — FY 2024
$200K
Total Revenue
$180K
Total Expenses
N/A
Net Assets
N/A
Employees
Revenue Sources
Program Expense Ratio N/A
Fundraising Efficiency 13.3%
Operating Reserve N/A
Liability-to-Asset 0.0%
Revenue Diversification N/A
Executive Compensation $0
Compared with Peers
FY 2023
Compared with 1,004 similar organizations (United States, Medical Research, $100K–$1M in expenses), FY 2023.
This organization Middle half of peers (P25–P75) Peer median
Ratio This org Peer median Position (P10 → P90)
Program expense ratio
Program expenses / total expenses · higher is better
87.1% 86.3%
P10P90
Above median
Admin expense ratio
Management and general / total expenses · lower is better
4.4% 10.6%
P10P90
Above median
Fundraising expense ratio
Fundraising expenses / total expenses · lower is better
8.5% 0.0%
P10P90
Bottom quarter
Operating reserve
Months of expenses covered by net assets · higher is better
17.7 mo 13.1 mo
P10P90
Above median
Liabilities to assets
Total liabilities / total assets · lower is better
0.4% 0.3%
P10P90
Below median
Revenue concentration
Share of revenue from the largest source · lower is better
78.2% 95.3%
P10P90
Above median
Revenue growth
Year over year revenue growth
24.4% 4.8%
P10P90
Expense growth
Year over year expense growth
404.0% 12.9%
P10P90
Surplus margin
Surplus as a share of revenue
27.6% -0.2%
P10P90
Impact
1 program
Outcome / Program People Served Cost / Service # Completed Duration
Targeted pediatric cancer treatments 300 $500.00 Lifetime
Financial History
Year Revenue Expenses Net Assets Program % Staff
2024 $200K $180K N/A
2023 $197K $143K $211K 87.1% 0
2022 $159K $28K $156K 11.7% 0
2021 $95K $31K N/A 0
Donor Reviews
Write a Review
No reviews yet

Be the first to share your experience with this organization.


Write a Review
Minimum 20 characters
Reviews appear after moderation (usually within 24 hours)
Organization Details
EIN
87-2231491
State
VA
City
VIRGINIA BCH
ZIP
23454-2601
Classification
H30
Category
Medical Research
Rating
4★
Coverage
A
Last Updated
Aug 2026
IRS Ruling Year
2021
Foundation Code
15
Form 990
On File
Is this your organization?

Claim it to manage this profile, add your board, financials and impact metrics, and lift your CharityAI™ rating.

Claim this Charity
Back to Search New Search